Hirmand Mohammad 4
4 · Turning Point Therapeutics, Inc. · Filed Feb 10, 2021
Insider Transaction Report
Form 4
Hirmand Mohammad
EVP and Chief Medical Officer
Transactions
- Award
Common Stock
2021-02-08+6,483→ 6,767 total - Award
Stock Option (right to buy)
2021-02-08+29,175→ 29,175 totalExercise: $140.01Exp: 2031-02-07→ Common Stock (29,175 underlying)
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]1/48th of the shares vest monthly following February 8, 2021.